| Identification | |
| Name: | Ranolazine HCl |
| CAS: | 95635-56-6 |
| Molecular Formula: | C24H33N3O4?2(HCl) |
| Molecular Weight: | 500.46 |
| InChI: | InChI=1/C24H33N3O4.2ClH/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3;;/h4-10,20,28H,11-17H2,1-3H3,(H,25,29);2*1H |
| Molecular Structure: | ![(C24H33N3O4?2(HCl)) (+/-)-4-[2-HYDROXY-3-(O-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETO-2',6'-XYLIDIDE DIHYDROCHLORIDE; n-(...](https://img.guidechem.com/casimg/95635-56-6.gif) |
| Properties | |
| Density: | g/cm3 |
| Solubility: | soluble in water |
| Appearance: | White Crystalline Powder |
| Specification: |
Ranolazine dihydrochloride , its cas register number is 95635-56-6. It also can be called N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride ; Ranexa ; and Renolazine . |
| Biological Activity: | Antianginal agent with antiarrhythmic properties that acts as a partial fatty acid oxidation inhibitor. Activates pyruvate dehydrogenase in ischemic myocytes to promote glucose oxidation, switching substrate utilization from fatty acids to glucose. Also shown to inhibit late I Na and I Kr currents. |
| Color: | off-white |
| Usage: |
Ranolazine dihydrochloride (CAS NO.95635-56-6) is an anti-ischemic agent which modulates myocardial metabolism, and is used for Antianginal. |
| Safety Data | |
 |
|
